Biosyent Inc
(TSXV:RX)
C$
11
-0.15 (-1.35%)
Market Cap: 127.46 Mil
Enterprise Value: 111.19 Mil
PE Ratio: 18.36
PB Ratio: 3.60
GF Score: 96/100 Q1 2022 Biosyent Inc Earnings Presentation Transcript
May 18, 2022 / NTS GMT
Release Date Price:
C$8.36
(-5.54%)
RenÃ;C. Goehrum
BioSyent Inc. - Chairman, CEO & President
Presentation
May 18, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* René C. Goehrum
BioSyent Inc. - Chairman, CEO & President
=====================
© -
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot